UK medtech company Brainomix has been granted FDA approval for a new feature for its artificial intelligence-powered stroke ...

AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for ...

The UK government has said it will invest up to £600 million ($764 million) in the creation of a centralised health data ...

AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for their TROP2-directed antibody-drug ...

PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and ...

European Commission President Ursula von der Leyen is scheduled to meet with EU pharma leaders today about how to respond to US tariffs, as fears build that levies specifically targeting the drug ...

An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial, leaving them sifting through the data for signals of efficacy.